Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 6, 1997, Pages 1137-1141

  Hedenstrom H ^a   Alm, C ^b   Kraft, M ^b   Grahnen A ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENOGASTRIC REFLUX; EFFERVESCENT TABLET; FEMALE; HEARTBURN; HUMAN; HUMAN EXPERIMENT; MALE; MICROCAPSULE; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; STOMACH PH; TABLET;

EID: 0030844194     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00264.x     Document Type: Article

References (11)

1. Ruth M, Månsson I, Sandberg N. The prevalence of symptoms suggestive of oesophageal disorders. Scand J Gastroenterol 1991; 26: 73-81.
2. Jones RH, Lydeard SE, Hobbs DFR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
3. Jones RH, Johnsson CD. Reflux symptoms in the general population. Hellen J Gastroenterol 1992; 5(Suppl.): 142.
4. Jones RH, Bosanquet N, Johnsson NJ, Chong Su-Lin. Cost effective management strategies for acid-peptic disorders. Br J Med Econ 1994; 7: 99-114.
5. Devis G, De Rop H, Du Ville L, et al. Fast onset of action on the intragastric pH with ranitidine effervescent tablets. Arch Int Pharmacodyn 1993; 322: 124-8.
6. Smout AJPM, Jonkman JHG, Peeters PAM, de Bruin H. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers. Aliment Pharmacol Ther 1995; 9, 51-6.
7. Loser C, Burlage M, Folsch UR. Influence of ranitidine and famotidine on the pH-profile in healthy volunteers. Randomised cross-over study of ranitidine effervescent tablets (300 mg) vs. famotidine film coated tablets. Arzneim-Forsch Drug Res 1994; 44: 626-9.
8. Hellke P, Elm M. Comparison of Zantac® standard tablets (ST) with Zantaz® effervescent tablets (ET) in the relief of symptoms of gastro-oesophageal reflux disease after single-dose intake. Scand J Gastroenterol 1996; 31(Suppl. 217): P46.
9. Engzelius JM, Solhaug JH, Knapstad LJ, Kjærsgaard P. Ranitidine effervescent tablets vs. famotidine wafer in the relief of episodic symptoms of GORD. Scand J Gastroenterol 1996; 31(Suppl. 217): P44.
10. Arnestad JS, Kleveland PM, Waldum HL. Faster and more consistent increase of intragastric pH with Zantac effervescent tablets with Lanzo enterocapsules. Scand J Gastroenterol 1996; 31(Suppl. 217): P4.
11. Naesdal J, Bodemar G, Walan A. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 1984; 19: 916-22.